Laurent Castéra - Genetic Mutations

Author Information

Laurent Castéra is affiliated with the Laboratory of Cancer Biology and Genetics at the Comprehensive Cancer Center François Baclesse, located in Caen, France. His work primarily revolves around the field of genetics, with a significant focus on cancer biology.

Research Contributions

Laurent Castéra has made substantial contributions to the field of genetics, particularly in areas related to cancer biology and liver diseases. His research encompasses a broad range of topics, including the analysis of DNA repair gene alterations in metastatic castration-resistant prostate cancer, the economic impact of non-alcoholic steatohepatitis, and the development of predictive tools like the Splicing Prediction Pipeline for mRNA splicing variants. His work also extends to the management of diabetes in cirrhosis patients and the evaluation of liver disease severity using non-invasive methods.

Aliases

Laurent Castéra is also known by several aliases including L Castera, L. Castera, Laurent Castera, and L Castéra. These variations appear in various publications and databases.

Publication and Citation Metrics

Metric	Value
Total Citation Count	28,935
H-index	78
Total Paper Count	389

Publications:

Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations

DOI: 10.3390/curroncol29040226

Year: 2022

Global multi-stakeholder endorsement of the MAFLD definition.

DOI: 10.1016/S2468-1253(22)00062-0

Year: 2022

SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effect on mRNA splicing.

DOI: 10.22541/au.164544915.57104749/v1

Year: 2022

Management of diabetes mellitus in patients with cirrhosis: an overview and joint statement.

DOI: 10.1016/j.diabet.2021.101272

Year: 2021

Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

DOI: 10.1111/liv.14825

Year: 2021

A new hybrid record linkage process to make epidemiological databases interoperable: application to the GEMO and GENEPSO studies involving BRCA1 and BRCA2 mutation carriers

DOI: 10.1186/s12874-021-01299-6

Year: 2021

Reply to: Correspondence on "EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update".

DOI: 10.1016/j.jhep.2021.10.008

Year: 2021

A Global Survey of Physicians Knowledge About Non-alcoholic Fatty Liver Disease.

DOI: 10.1016/j.cgh.2021.06.048

Year: 2021

Elastography Methods to Assess Chronic Liver Diseases: A Critical Comparison

DOI: 10.1007/978-3-030-74132-7_10

Year: 2021

Two-dimensional shear wave elastography predicts survival in advanced chronic liver disease

DOI: 10.1136/gutjnl-2020-323419

Year: 2021

What are the Global Implications?

How Common are BRCA1 and BRCA2 Mutations?

How do PAHs cause genetic mutations?

What is the Future of CFTR Gene Research?

Is There a Cure for Autism Spectrum Disorder?

Are All Tobacco Products Equally Harmful?

What Makes a Mutation Harmful?

What Are the Implications of Genetic Research?

What are the Applications of Populace Genomics?

What Role Does Biotechnology Play in Agriculture?

Partnered Content Networks

Relevant Topics